Drug Shortage Report for APO-GABAPENTIN CAPSULES

Last updated on 2017-07-13 History
Report ID 661
Drug Identification Number 02244305
Brand name APO-GABAPENTIN CAPSULES
Common or Proper name GABAPENTIN
Company Name APOTEX INC
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-01
Estimated end date 2017-07-31
Actual end date 2017-07-12
Shortage status Resolved
Updated date 2017-07-13
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2017-07-13 French Compare
v17 2017-07-13 English Compare
v16 2017-06-08 French Compare
v15 2017-06-08 English Compare
v14 2017-05-13 English Compare
v13 2017-05-12 French Compare
v12 2017-05-12 English Compare
v11 2017-05-10 French Compare
v10 2017-05-10 English Compare
v9 2017-05-10 French Compare
v8 2017-05-10 English Compare
v7 2017-04-04 French Compare
v6 2017-04-04 English Compare
v5 2017-03-18 English Compare
v4 2017-03-17 French Compare
v3 2017-03-17 English Compare
v2 2017-03-11 French Compare
v1 2017-03-11 English Compare